Literature DB >> 6248241

Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region.

M Katinka, M Yaniv, M Vasseur, D Blangy.   

Abstract

Established mouse cell lines, primary cultures of mouse cells, and differentiated cell lines derived from mouse teratocarcinoma are permissive to polyoma virus. No viral early or late functions are expressed upon infection and penetration of multipotential embryonal cell lines. Polyoma mutants capable of growth on these cells were isolated and their DNA was cloned. Both the linear cloned viral DNA and a hybrid composed of mutant Bam HI (0.58) to Bgl I (0.72) 750 bp fragment (containing the origin of replication) ligated to the complementary wild-type 4.5 kb fragment are able to multiply on PCC4 embryonal carcinoma cells. The nucleotide sequence of two mutants indicated a genomic rearrangement on the late side of the origin, in which a deletion starting at nucleotides 46 (Py 204) and 77 (Py97) and terminating for both in nucleotide 107 was replaced by the duplication of a downstream late sequence starting at nucleotide 138 (Py 204) and 157 Py97) and terminating in nucleotide 220. The fact that the sequence rearrangements permit the expression of early and late functions upon infection suggests that this region participates in the control of early transcription. This control is different in embryonal and differentiated mouse cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248241     DOI: 10.1016/0092-8674(80)90625-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  67 in total

1.  Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution.

Authors:  S Zhang; G Magnusson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA.

Authors:  M Satake; K Furukawa; Y Ito
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Nuclear activity from F9 embryonal carcinoma cells binding specifically to the enhancers of wild-type polyoma virus and PyEC mutant DNAs.

Authors:  F K Fujimura
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

4.  Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer.

Authors:  Y Kamachi; E Ogawa; M Asano; S Ishida; Y Murakami; M Satake; Y Ito; K Shigesada
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 5.  What history tells us XXXV. Enhancers: their existence and characteristics have raised puzzling issues since their discovery.

Authors:  Michel Morange
Journal:  J Biosci       Date:  2014-12       Impact factor: 1.826

6.  Negative transcriptional regulatory element that functions in embryonal carcinoma cells.

Authors:  K Ariizumi; H Takahashi; M Nakamura; H Ariga
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

7.  Replicative cis-advantage of polyomavirus regulatory region mutants in different murine cell lines.

Authors:  V De Simone; P Amati
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells.

Authors:  F Hilberg; C Stocking; W Ostertag; M Grez
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

9.  Retroviral vector gene expression in F9 embryonal carcinoma cells.

Authors:  E Linney; S D Neill; D S Prestridge
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.